Ares Financial Consulting’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Ares Financial Consulting's NVS Position: Q3 2026 in Review
Ares Financial Consulting held its Novartis (NVS) position steady in Q3 2026 at 457 shares worth $65.2K. The position accounts for 0.05% of the portfolio, ranked #191.
Ares Financial Consulting first reported a position in NVS in Q1 2026 and has held it in 3 quarters since. The position peaked at $84.8K in Q1 2026. 1,543 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Ares Financial Consulting held 457 shares of Novartis worth $65.2K as of Q3 2026.
- Ares Financial Consulting left its Novartis share count unchanged in Q3 2026.
- Novartis made up 0.05% of Ares Financial Consulting's portfolio in Q3 2026, its #191 holding.
- Ares Financial Consulting first reported a position in Novartis in Q1 2026 and has held it in 3 quarters since.
- Ares Financial Consulting's Novartis position peaked at $84.8K in Q1 2026.
- 1,543 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.